Jolt Health Inc.
JTHTF
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -39.74% | 457.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.74% | 457.85% | |||
| Operating Income | 39.74% | -457.85% | |||
| Income Before Tax | 65.50% | -856.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 65.50% | -856.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 65.50% | -856.30% | |||
| EBIT | 39.74% | -457.85% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 65.53% | -853.75% | |||
| Normalized Basic EPS | 41.07% | -460.00% | |||
| EPS Diluted | 65.53% | -853.75% | |||
| Normalized Diluted EPS | 41.07% | -460.00% | |||
| Average Basic Shares Outstanding | -0.06% | 0.06% | |||
| Average Diluted Shares Outstanding | -0.06% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||